While the initial image might be one of robots moving test tubes around or some intransigent HAL-like computer questioning human commands, the reality of applying artificial intelligence (AI) to drug discovery is rather more mundane - but hopefully productive - for Interprotein.
The Japanese peptide R&D-focused venture's new collaborative agreement with Tokyo-based A.I. Squared to develop the application of AI to the drug discovery process is designed rather to overcome some of...